Ardelyx, Inc. (ARDX): Free Cash Flow
-$43.98M
Year ended 2025-12-31
-$17.92M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$43.98M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$45.82M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$90.06M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$70.10M | n/m | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | -$154.42M | n/m | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | -$81.76M | n/m | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | -$76.81M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$70.58M | n/m | 2021-03-08, From 2018-01-01 |
| 2017-12-31 | -$67.55M | n/m | 2020-03-06, From 2017-01-01 |
| 2016-12-31 | -$97.40M | n/m | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | -$75.29M | n/m | 2018-03-14, From 2015-01-01 |
| 2014-12-31 | $11.54M | +652.8% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $1.53M | -93.0% | 2016-03-04, From 2013-01-01 |
| 2012-12-31 | $21.85M | n/a | 2015-03-05, From 2012-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$43.98M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $195.80M | +3.9% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$561.10M | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$6.31M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$158.89M | n/m |
| MannKind Corp (MNKD) | 2025-12-31 | $13.69M | -58.3% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $28.84M | +101.3% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$447.01M | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $54.87M | +488.0% |
Compare ARDX, INVA, SVA, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗